| 1 | Vaginal Neoplasms | 46.2% |
| 2 | Vulvar Neoplasms | 46.2% |
| 3 | Fallopian Tube Neoplasms | 43.4% |
| 4 | Endometritis | 32.8% |
| 5 | Endometrial Hyperplasia | 29% |
| 6 | Pyometra | 29% |
| 7 | Urologic Neoplasms | 28.2% |
| 8 | Uterine Inversion | 27.3% |
| 9 | ovarian neoplasm | 24.6% |
| 10 | Endometriosis | 24.4% |
| 11 | Vaginal Diseases | 24.4% |
| 12 | Vulvar Diseases | 24.4% |
| 13 | Endometrioma | 24.4% |
| 14 | Uterine hemorrhage | 23.4% |
| 15 | Uterine Prolapse | 23.2% |
| 16 | Vaginal Prolapse | 23.2% |
| 17 | Uterine Rupture | 23.1% |
| 18 | Uterine Cervicitis | 21.7% |
| 19 | Urologic Diseases | 20.7% |
| 20 | Uterine Cervical Incompetence | 19.9% |
| 21 | Infertility | 19.9% |
| 22 | Salpingitis | 19.2% |
| 23 | Vulvovaginitis | 19.2% |
| 24 | Bladder Neoplasm | 18.7% |
| 25 | Kidney Neoplasm | 18.7% |
| 26 | Ureteral Neoplasms | 18.7% |
| 27 | Urethral Neoplasms | 18.7% |
| 28 | Uterine Perforation | 17.5% |
| 29 | Metrorrhagia | 17.4% |
| 30 | Urogenital Abnormalities | 17.3% |
| 31 | granulosa cell tumor | 17% |
| 32 | Carcinoma, Ovarian Epithelial | 17% |
| 33 | Oophoritis | 16.1% |
| 34 | Vaginitis | 16.1% |
| 35 | Vulvitis | 16.1% |
| 36 | Vaginal Discharge | 16.1% |
| 37 | Vulvodynia | 16.1% |
| 38 | Carcinoma, Endometrioid | 15.9% |
| 39 | Pregnancy Complications | 15.4% |
| 40 | Sexually Transmitted Diseases | 14.8% |
| 41 | Menorrhagia | 14.6% |
| 42 | Genital Herpes | 14.2% |
| 43 | Mesoblastic Nephroma | 13.4% |
| 44 | Candidiasis, Vulvovaginal | 13.4% |
| 45 | Vesicovaginal Fistula | 13.2% |
| 46 | Ovarian Diseases | 13.2% |
| 47 | Pregnancy Complications, Neoplastic | 13.1% |
| 48 | Adnexitis | 13% |
| 49 | Pruritus Vulvae | 13% |
| 50 | Vaginal Fistula | 13% |
| 51 | Pelvic Inflammatory Disease | 13% |
| 52 | Renal Cell Carcinoma | 12.8% |
| 53 | Papillary Renal Cell Carcinoma | 12.8% |
| 54 | Nephroblastoma | 12.6% |
| 55 | Abdominal Neoplasms | 12.4% |
| 56 | Bladder Exstrophy | 12.4% |
| 57 | Epispadias | 12.4% |
| 58 | Head and Neck Neoplasms | 12.4% |
| 59 | Soft Tissue Neoplasms | 12.4% |
| 60 | Thoracic Neoplasms | 12.4% |
| 61 | Tuberculosis, Renal | 12.3% |
| 62 | Leukorrhea | 12% |
| 63 | Parametritis | 12% |
| 64 | Urinary Bladder Diseases | 11.9% |
| 65 | Kidney Diseases | 11.9% |
| 66 | Ureteral Diseases | 11.9% |
| 67 | Urethral Diseases | 11.9% |
| 68 | Urination Disorders | 11.9% |
| 69 | Urolithiasis | 11.9% |
| 70 | Genital Neoplasms, Male | 11.7% |
| 71 | Anuria | 11.2% |
| 72 | Ureterolithiasis | 11.2% |
| 73 | Nephrolithiasis | 11.2% |
| 74 | Multicystic Dysplastic Kidney | 11.1% |
| 75 | Dyspareunia | 11% |
| 76 | Corpus Luteum Cyst | 11% |
| 77 | Ovarian Cysts | 11% |
| 78 | Digestive System Neoplasms | 10.3% |
| 79 | Endocrine Gland Neoplasms | 10.3% |
| 80 | Eye Neoplasms | 10.3% |
| 81 | Nervous System Neoplasms | 10.3% |
| 82 | Bone neoplasms | 10.1% |
| 83 | Skin Neoplasms | 10.1% |
| 84 | Hematologic Neoplasms | 10.1% |
| 85 | Urinary tract infection | 10.1% |
| 86 | Horseshoe Kidney | 9.9% |
| 87 | Splenic Neoplasms | 9.9% |
| 88 | Bacterial Vaginosis | 9.8% |
| 89 | Urinary Bladder Fistula | 9.8% |
| 90 | Trichomonas Vaginitis | 9.7% |
| 91 | Ovarian Hyperstimulation Syndrome | 9.7% |
| 92 | Bladder neck obstruction | 9.7% |
| 93 | Denys-Drash Syndrome | 9.1% |
| 94 | Kidney Calculi | 8.7% |
| 95 | Ureteral Calculi | 8.7% |
| 96 | Hermaphroditism | 8.6% |
| 97 | Parathyroid Neoplasms | 8.6% |
| 98 | Peritoneal Neoplasms | 8.6% |
| 99 | Disorders of Sex Development | 8.6% |
| 100 | Thyroid Neoplasm | 8.6% |
| 101 | Thyroid carcinoma | 8.6% |
| 102 | Hypospadias | 8.5% |
| 103 | Testicular Neoplasms | 8.5% |
| 104 | Polycystic Ovary Syndrome | 8.3% |
| 105 | Polyhydramnios | 8.3% |
| 106 | Obstetric Labor Complications | 8.3% |
| 107 | Ectopic Pregnancy | 8.3% |
| 108 | Pregnancy, Prolonged | 8.3% |
| 109 | Puerperal Disorders | 8.3% |
| 110 | Oligohydramnios | 8.3% |
| 111 | Prenatal Injuries | 8.3% |
| 112 | Anovulation | 8.1% |
| 113 | Premature Menopause | 8% |
| 114 | Multiple Endocrine Neoplasia | 8% |
| 115 | Abruptio Placentae | 7.8% |
| 116 | Placenta Accreta | 7.8% |
| 117 | Paraneoplastic Encephalomyelitis | 7.8% |
| 118 | Cystitis | 7.8% |
| 119 | Hydronephrosis | 7.8% |
| 120 | Hyperoxaluria | 7.8% |
| 121 | Kidney Cortex Necrosis | 7.8% |
| 122 | Kidney Papillary Necrosis | 7.8% |
| 123 | Nephritis | 7.8% |
| 124 | Nephrosclerosis | 7.8% |
| 125 | Nephrosis | 7.8% |
| 126 | Perinephritis | 7.8% |
| 127 | Kidney Failure | 7.8% |
| 128 | Uremia | 7.8% |
| 129 | Ureteral obstruction | 7.8% |
| 130 | Ureterocele | 7.8% |
| 131 | Urethral Obstruction | 7.8% |
| 132 | Urethritis | 7.8% |
| 133 | Vesico-Ureteral Reflux | 7.8% |
| 134 | Urinary Retention | 7.8% |
| 135 | Oxalosis | 7.8% |
| 136 | Renal Insufficiency | 7.8% |
| 137 | Trophoblastic Neoplasms | 7.7% |
| 138 | Hamartoma | 7.7% |
| 139 | Mammary Neoplasms, Experimental | 7.7% |
| 140 | Neoplasms, Hormone-Dependent | 7.7% |
| 141 | Neoplasms, Multiple Primary | 7.7% |
| 142 | Paraneoplastic Syndromes | 7.7% |
| 143 | Precancerous Conditions | 7.7% |
| 144 | Neoplasms, Second Primary | 7.7% |
| 145 | Pancreatic Neoplasm | 7.6% |
| 146 | Chorioamnionitis | 7.5% |
| 147 | Pyelocystitis | 7.5% |
| 148 | Retroperitoneal Neoplasms | 7.3% |
| 149 | Uterine Diseases | 7.3% |
| 150 | Tracheal Neoplasms | 7.1% |
| 151 | Acanthoma | 7.1% |
| 152 | Fetal Diseases | 6.9% |
| 153 | Pregnancy Complications, Cardiovascular | 6.9% |
| 154 | Pyelonephritis | 6.8% |
| 155 | Pregnancy Complications, Hematologic | 6.7% |
| 156 | Pregnancy Complications, Infectious | 6.7% |
| 157 | Fetal Death | 6.6% |
| 158 | Perinatal death | 6.6% |
| 159 | Diabetes Insipidus | 6.6% |
| 160 | Hepatorenal Syndrome | 6.6% |
| 161 | Morning Sickness | 6.6% |
| 162 | Puerperal Infection | 6.6% |
| 163 | Penile Neoplasms | 6.5% |
| 164 | Prostatic Neoplasms | 6.5% |
| 165 | Bacteriuria | 6.5% |
| 166 | Diabetic Nephropathy | 6.5% |
| 167 | Glycosuria | 6.5% |
| 168 | Hematuria | 6.5% |
| 169 | Renal hypertension | 6.5% |
| 170 | Oliguria | 6.5% |
| 171 | Polyuria | 6.5% |
| 172 | Postpartum Hemorrhage | 6.5% |
| 173 | Proteinuria | 6.5% |
| 174 | Pyuria | 6.5% |
| 175 | Renal Artery Obstruction | 6.5% |
| 176 | Renal Artery Stenosis | 6.5% |
| 177 | Urinary Calculi | 6.5% |
| 178 | Cystocele | 6.5% |
| 179 | Nephrocalcinosis | 6.5% |
| 180 | Urinary Incontinence | 6.5% |
| 181 | Uterine Neoplasms | 6.5% |
| 182 | Uterine Cancer | 6.5% |
| 183 | Cyst | 6.2% |
| 184 | Neoplastic Processes | 6.2% |
| 185 | Neoplastic Syndromes, Hereditary | 6.2% |
| 186 | Esophageal Neoplasms | 6.1% |
| 187 | Neoplasms, Experimental | 6.1% |
| 188 | Chlamydia Infections | 6.1% |
| 189 | Gonorrhea | 6.1% |
| 190 | Mouth Neoplasms | 6% |
| 191 | Central Nervous System Neoplasms | 6% |
| 192 | Vascular Neoplasms | 6% |
| 193 | Thymus Neoplasms | 6% |
| 194 | Genital Neoplasms, Female | 5.9% |
| 195 | Breast Neoplasms, Male | 5.8% |
| 196 | Triple Negative Breast Neoplasms | 5.8% |
| 197 | Glomerulonephritis | 5.8% |
| 198 | Glycosuria, Renal | 5.8% |
| 199 | Nephritis, Interstitial | 5.8% |
| 200 | Lipoid nephrosis | 5.8% |
| 201 | Nephrotic Syndrome | 5.8% |
| 202 | Pyelitis | 5.8% |
| 203 | Pyonephrosis | 5.8% |
| 204 | Urethral Stenosis | 5.8% |
| 205 | Nephrogenic Diabetes Insipidus | 5.8% |
| 206 | Congenital Nephrogenic Diabetes Insipidus | 5.8% |
| 207 | Acute kidney injury | 5.8% |
| 208 | Urethral stricture | 5.8% |
| 209 | Carcinoma, Lobular | 5.8% |
| 210 | Enuresis | 5.7% |
| 211 | Gonadal Dysgenesis | 5.6% |
| 212 | Thyroid Nodule | 5.6% |
| 213 | Adrenogenital Syndrome | 5.6% |
| 214 | Ovotesticular Disorders of Sex Development | 5.6% |
| 215 | Gestational Diabetes | 5.6% |
| 216 | Syphilis | 5.4% |
| 217 | Hyperandrogenism | 5.2% |
| 218 | Endometrial Stromal Sarcoma | 5.2% |
| 219 | Neoplasms, Radiation-Induced | 5.1% |
| 220 | Adrenal Gland Neoplasms | 5% |
| 221 | Gastrointestinal Neoplasms | 5% |
| 222 | Liver neoplasms | 5% |
| 223 | Uveal Neoplasms | 5% |
| 224 | Lymphogranuloma Venereum | 5% |
| 225 | Sebaceous Gland Neoplasms | 4.9% |
| 226 | Spinal Neoplasms | 4.9% |
| 227 | Bone Marrow Neoplasms | 4.9% |
| 228 | Azotemia | 4.9% |
| 229 | Multiple Endocrine Neoplasia Type 1 | 4.9% |
| 230 | Thymoma | 4.9% |
| 231 | Abortion, Habitual | 4.9% |
| 232 | Dystocia | 4.9% |
| 233 | Eclampsia | 4.9% |
| 234 | Fetal Membranes, Premature Rupture | 4.9% |
| 235 | Placental Insufficiency | 4.9% |
| 236 | Pre-Eclampsia | 4.9% |
| 237 | Prenatal Exposure Delayed Effects | 4.9% |
| 238 | HELLP Syndrome | 4.9% |
| 239 | Placenta, Retained | 4.9% |
| 240 | Meningioma | 4.9% |
| 241 | AIDS-Associated Nephropathy | 4.9% |
| 242 | Choriocarcinoma | 4.8% |
| 243 | Prostatic Neoplasms, Castration-Resistant | 4.8% |
| 244 | Albuminuria | 4.8% |
| 245 | Hemoglobinuria | 4.8% |
| 246 | Hypertension, Renovascular | 4.8% |
| 247 | Urge Incontinence | 4.8% |
| 248 | Balkan Nephropathy | 4.8% |
| 249 | Endometrial Neoplasms | 4.8% |
| 250 | Focal glomerulosclerosis | 4.8% |
| 251 | Kidney Failure, Chronic | 4.8% |
| 252 | Carcinoma, Pancreatic Ductal | 4.8% |
| 253 | Leydig Cell Tumor | 4.7% |
| 254 | Carcinoma 256, Walker | 4.6% |
| 255 | Carcinoma, Ehrlich Tumor | 4.6% |
| 256 | Dermoid Cyst | 4.6% |
| 257 | Carcinoma, Lewis Lung | 4.6% |
| 258 | Liver Neoplasms, Experimental | 4.5% |
| 259 | Leukemia, Experimental | 4.4% |
| 260 | Leukoplakia, Oral | 4.2% |
| 261 | Tuberous Sclerosis | 4.2% |
| 262 | Paraneoplastic Cerebellar Degeneration | 4.2% |
| 263 | Polycystic Kidney Diseases | 4.2% |
| 264 | Glomerulonephritis, Membranoproliferative | 4.2% |
| 265 | Diurnal Enuresis | 4.2% |
| 266 | Renal Aminoacidurias | 4.1% |
| 267 | Fanconi Syndrome | 4.1% |
| 268 | Pseudohypoaldosteronism | 4.1% |
| 269 | Liddle Syndrome | 4.1% |
| 270 | Erythroplasia | 4.1% |
| 271 | Follicular cyst | 4.1% |
| 272 | leukemia | 4.1% |
| 273 | Mucocele | 4.1% |
| 274 | Neoplasms, Germ Cell and Embryonal | 4.1% |
| 275 | Neoplasms, Glandular and Epithelial | 4.1% |
| 276 | Pilonidal Cyst | 4.1% |
| 277 | Thyroglossal Cyst | 4.1% |
| 278 | Synovial Cyst | 4.1% |
| 279 | Germ Cell Cancer | 4.1% |
| 280 | Aberrant Crypt Foci | 4.1% |
| 281 | Hemolytic-Uremic Syndrome | 4.1% |
| 282 | Abortion, Veterinary | 4.1% |
| 283 | Pregnancy Complications, Parasitic | 4.1% |
| 284 | Nose Neoplasms | 4% |
| 285 | Lactation Disorder | 3.9% |
| 286 | Mastitis | 3.9% |
| 287 | Neuroectodermal Tumors | 3.9% |
| 288 | Depression, Postpartum | 3.9% |
| 289 | Embryo Loss | 3.9% |
| 290 | Fetal Resorption | 3.9% |
| 291 | Meningeal Neoplasms | 3.9% |
| 292 | Hyperemesis Gravidarum | 3.9% |
| 293 | Renal Osteodystrophy | 3.9% |
| 294 | Renal rickets | 3.9% |
| 295 | Melanoma, Experimental | 3.9% |
| 296 | Acoustic Neuroma | 3.9% |
| 297 | Sarcoma, Experimental | 3.8% |
| 298 | Leukemia, Radiation-Induced | 3.8% |
| 299 | Palatal Neoplasms | 3.8% |
| 300 | Neoplasms, Neuroepithelial | 3.8% |
| 301 | Gliomatosis cerebri | 3.8% |
| 302 | insulinoma | 3.7% |
| 303 | Hepatocellular Adenoma | 3.7% |
| 304 | Vipoma | 3.7% |
| 305 | Pituitary Adenoma | 3.7% |
| 306 | Pituitary Neoplasms | 3.7% |
| 307 | Limbic Encephalitis | 3.7% |
| 308 | Gastrinoma | 3.7% |
| 309 | Glucagonoma | 3.7% |
| 310 | Renal tubular acidosis | 3.6% |
| 311 | Turner Syndrome | 3.6% |
| 312 | Retinoblastoma | 3.6% |
| 313 | Anti-Glomerular Basement Membrane Disease | 3.5% |
| 314 | Hydatidiform Mole | 3.5% |
| 315 | Lupus Nephritis | 3.5% |
| 316 | Polycystic Kidney, Autosomal Dominant | 3.4% |
| 317 | Cystinuria | 3.4% |
| 318 | Atypical Hemolytic Uremic Syndrome | 3.4% |
| 319 | Leukoplakia | 3.4% |
| 320 | Lymphocele | 3.4% |
| 321 | Pancreatic Cyst | 3.4% |
| 322 | Ear Neoplasms | 3.3% |
| 323 | Eyelid Neoplasms | 3.3% |
| 324 | Lung Neoplasms | 3.3% |
| 325 | Pleural Neoplasms | 3.3% |
| 326 | Fetal Growth Retardation | 3.3% |
| 327 | Barrett Esophagus | 3.3% |
| 328 | Breast Cyst | 3.3% |
| 329 | Histiocytic Disorders, Malignant | 3.3% |
| 330 | Actinic keratosis | 3.3% |
| 331 | Mediastinal Cyst | 3.3% |
| 332 | Neoplasm Invasiveness | 3.3% |
| 333 | Neoplasm Metastasis | 3.3% |
| 334 | Neoplasm Recurrence, Local | 3.3% |
| 335 | Parovarian Cyst | 3.3% |
| 336 | Pericardial Cyst | 3.3% |
| 337 | Thymic Cyst | 3.3% |
| 338 | Carcinogenesis | 3.3% |
| 339 | Myxoid cyst | 3.3% |
| 340 | Metastasis | 3.3% |
| 341 | Lambert-Eaton Myasthenic Syndrome | 3.3% |
| 342 | Embolism, Amniotic Fluid | 3.3% |
| 343 | Fetal Hypoxia | 3.3% |
| 344 | Fetal Alcohol Spectrum Disorders | 3.3% |
| 345 | Brain Neoplasms | 3.3% |
| 346 | Salivary Gland Neoplasms | 3.3% |
| 347 | Spinal Cord Neoplasms | 3.3% |
| 348 | Tongue Neoplasms | 3.3% |
| 349 | Kallmann Syndrome | 3.3% |
| 350 | Breech Presentation | 3.2% |
| 351 | Carcinosarcoma | 3.2% |
| 352 | Hemangiosarcoma | 3.2% |
| 353 | Leukemia L1210 | 3.2% |
| 354 | Leukemia P388 | 3.2% |
| 355 | lymphangiosarcoma | 3.2% |
| 356 | Prolactinoma | 3.2% |
| 357 | Growth Hormone-Secreting Pituitary Adenoma | 3.2% |
| 358 | Stillbirth | 3.2% |
| 359 | melanoma | 3.2% |
| 360 | Premature Birth | 3.2% |
| 361 | Optic Nerve Glioma | 3% |
| 362 | Zellweger Syndrome | 3% |
| 363 | Lymphomatoid Granulomatosis | 3% |
| 364 | Opsoclonus-Myoclonus Syndrome | 3% |
| 365 | Sarcoma 180 | 2.9% |
| 366 | Hyperphosphaturia | 2.9% |
| 367 | Klinefelter Syndrome | 2.9% |
| 368 | Meningeal Carcinomatosis | 2.9% |
| 369 | Pharyngeal Neoplasms | 2.9% |
| 370 | Central Nervous System Cysts | 2.8% |
| 371 | Medulloblastoma | 2.8% |
| 372 | Bile Duct Neoplasms | 2.8% |
| 373 | gallbladder neoplasm | 2.8% |
| 374 | Intestinal Neoplasms | 2.8% |
| 375 | Stomach Neoplasms | 2.8% |
| 376 | Composite Lymphoma | 2.8% |
| 377 | Polycythemia Vera | 2.8% |
| 378 | Lymphoma | 2.8% |
| 379 | Adenomatous Polyposis Coli | 2.8% |
| 380 | Leukemia, Plasma Cell | 2.7% |
| 381 | Adenoma, Acidophil | 2.7% |
| 382 | Ganglioneuroma | 2.7% |
| 383 | Glioma | 2.7% |
| 384 | Malignant Glioma | 2.7% |
| 385 | Myelitis, Transverse | 2.7% |
| 386 | Basal Cell Nevus Syndrome | 2.6% |
| 387 | Basal cell carcinoma | 2.6% |
| 388 | Carcinoma, Papillary | 2.6% |
| 389 | Squamous cell carcinoma | 2.6% |
| 390 | Chondrosarcoma | 2.6% |
| 391 | Craniopharyngioma | 2.6% |
| 392 | Cystadenoma | 2.6% |
| 393 | leiomyosarcoma | 2.6% |
| 394 | liposarcoma | 2.6% |
| 395 | Mesothelioma | 2.6% |
| 396 | synovial sarcoma | 2.6% |
| 397 | Neuroectodermal Tumor, Melanotic | 2.6% |
| 398 | Angiomyolipoma | 2.6% |
| 399 | Clear Cell Sarcoma of Soft Tissue | 2.6% |
| 400 | Alveolar Soft Part Sarcoma | 2.6% |
| 401 | Neuroendocrine Tumors | 2.6% |
| 402 | Galactorrhea | 2.6% |
| 403 | Sarcoma, Myeloid | 2.6% |
| 404 | Carcinoma, Basal Cell | 2.6% |
| 405 | Laryngeal neoplasm | 2.5% |
| 406 | Meconium Aspiration Syndrome | 2.5% |
| 407 | Bronchial Neoplasms | 2.5% |
| 408 | Adenoma | 2.4% |
| 409 | Ameloblastoma | 2.4% |
| 410 | Angiokeratoma | 2.4% |
| 411 | Carcinoma | 2.4% |
| 412 | Chordoma | 2.4% |
| 413 | Hemangioma | 2.4% |
| 414 | hemangiopericytoma | 2.4% |
| 415 | Lymphangioma | 2.4% |
| 416 | Mesenchymoma | 2.4% |
| 417 | Nevus | 2.4% |
| 418 | Teratoma | 2.4% |
| 419 | Hepatoblastoma | 2.4% |
| 420 | Mixed Tumor, Mullerian | 2.4% |
| 421 | Germinoma | 2.4% |
| 422 | Teratocarcinoma | 2.4% |
| 423 | Angiofibroma | 2.4% |
| 424 | Multiple Pulmonary Nodules | 2.4% |
| 425 | Sarcoma | 2.4% |
| 426 | Epithelioma | 2.4% |
| 427 | Supratentorial Neoplasms | 2.4% |
| 428 | Adrenocortical carcinoma | 2.4% |
| 429 | Carcinoid Tumor | 2.4% |
| 430 | Neurilemmoma | 2.4% |
| 431 | Hutchinson's Melanotic Freckle | 2.4% |
| 432 | Melanoma, Amelanotic | 2.4% |
| 433 | Choledochal Cyst | 2.4% |
| 434 | Peutz-Jeghers Syndrome | 2.3% |
| 435 | Cystadenocarcinoma | 2.3% |
| 436 | Fibrosarcoma | 2.3% |
| 437 | Osteosarcoma | 2.3% |
| 438 | Mucoepidermoid Carcinoma | 2.3% |
| 439 | Astrocytoma | 2.1% |
| 440 | Ependymoma | 2.1% |
| 441 | oligodendroglioma | 2.1% |
| 442 | Ganglioglioma | 2.1% |
| 443 | gliosarcoma | 2.1% |
| 444 | Anaplastic astrocytoma | 2.1% |
| 445 | Anaplastic Oligodendroglioma | 2.1% |
| 446 | Hypopharyngeal Neoplasms | 2.1% |
| 447 | Pleural Effusion, Malignant | 2.1% |
| 448 | Hypopharyngeal Cancer | 2.1% |
| 449 | Adenofibroma | 2.1% |
| 450 | Fibroadenoma | 2.1% |
| 451 | Malignant Fibrous Histiocytoma | 2.1% |
| 452 | Parotid Neoplasms | 2.1% |
| 453 | Nelson Syndrome | 2.1% |
| 454 | Brain Stem Neoplasms | 2% |
| 455 | Malignant Carcinoid Syndrome | 2% |
| 456 | Pancreatic Pseudocyst | 2% |
| 457 | Plasmacytoma | 2% |
| 458 | Malignant histiocytosis | 1.9% |
| 459 | Lymphatic Metastasis | 1.9% |
| 460 | Neoplasms, Unknown Primary | 1.9% |
| 461 | Leukemic Infiltration | 1.9% |
| 462 | Histiocytic sarcoma | 1.9% |
| 463 | Neoplasm Micrometastasis | 1.9% |
| 464 | Bowen's Disease | 1.9% |
| 465 | Paraganglioma | 1.9% |
| 466 | Rhabdomyosarcoma | 1.9% |
| 467 | Giant Cell Tumor of Bone | 1.9% |
| 468 | Glioblastoma | 1.9% |
| 469 | Neuroblastoma | 1.9% |
| 470 | Glioblastoma Multiforme | 1.9% |
| 471 | Nasopharyngeal carcinoma | 1.9% |
| 472 | Lymphangioleiomyomatosis | 1.8% |
| 473 | Cecal Neoplasms | 1.8% |
| 474 | Duodenal Neoplasms | 1.8% |
| 475 | Choroid Plexus Papilloma | 1.8% |
| 476 | Dermatofibrosarcoma | 1.8% |
| 477 | Dermatofibrosarcoma Protuberans | 1.8% |
| 478 | Tonsillar Neoplasms | 1.7% |
| 479 | Ganglioneuroblastoma | 1.7% |
| 480 | Cerebellar Neoplasms | 1.7% |
| 481 | Neurofibrosarcoma | 1.7% |
| 482 | Nasopharyngeal Neoplasms | 1.6% |
| 483 | Hodgkin Disease | 1.6% |
| 484 | Lymphoma, Non-Hodgkin | 1.6% |
| 485 | Adenocarcinoma | 1.6% |
| 486 | Carcinoma in Situ | 1.6% |
| 487 | Carcinoma, Transitional Cell | 1.6% |
| 488 | Phyllodes Tumor | 1.6% |
| 489 | Dysgerminoma | 1.6% |
| 490 | Hemangioendothelioma | 1.6% |
| 491 | Lipoma | 1.6% |
| 492 | Myoma | 1.6% |
| 493 | Myxoma | 1.6% |
| 494 | Neuroma | 1.6% |
| 495 | Papilloma | 1.6% |
| 496 | Pseudomyxoma Peritonei | 1.6% |
| 497 | Seminoma | 1.6% |
| 498 | Papillomatosis | 1.6% |
| 499 | Angiolipoma | 1.6% |
| 500 | Myelolipoma | 1.6% |
| 501 | Neoplasms, Bone Tissue | 1.6% |
| 502 | Neoplasms, Fibrous Tissue | 1.6% |
| 503 | Smooth Muscle Tumor | 1.6% |
| 504 | Adenomatosis, Pulmonary | 1.6% |
| 505 | Adenomatous Polyps | 1.6% |
| 506 | Carcinoma, Large Cell | 1.6% |
| 507 | Carcinoma, Small Cell | 1.6% |
| 508 | Desmoplastic Small Round Cell Tumor | 1.6% |
| 509 | Chondroma | 1.6% |
| 510 | Enchondroma | 1.6% |
| 511 | Colorectal Neoplasms | 1.6% |
| 512 | Pheochromocytoma | 1.6% |
| 513 | Alveolar rhabdomyosarcoma | 1.6% |
| 514 | Familial Hypophosphatemic Rickets | 1.6% |
| 515 | Carcinoid Heart Disease | 1.6% |
| 516 | Xeroderma Pigmentosum | 1.5% |
| 517 | Appendiceal Neoplasms | 1.5% |
| 518 | Colonic Neoplasms | 1.5% |
| 519 | Rectal Neoplasms | 1.5% |
| 520 | Paranasal Sinus Neoplasms | 1.5% |
| 521 | Primary amyloidosis | 1.4% |
| 522 | Hydrops Fetalis | 1.3% |
| 523 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 524 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 525 | Maxillary Sinus Neoplasms | 1.2% |
| 526 | Adenoid Cystic Carcinoma | 1.2% |
| 527 | fibroma | 1.2% |
| 528 | Fibromatosis | 1.2% |
| 529 | Osteoblastoma | 1.2% |
| 530 | Osteoma | 1.2% |
| 531 | Rhabdomyoma | 1.2% |
| 532 | Chondromatosis | 1.2% |
| 533 | Adenocarcinoma, Clear Cell | 1.2% |
| 534 | Cholangiocarcinoma | 1.2% |
| 535 | Cervical Intraepithelial Neoplasia | 1.2% |
| 536 | Hemangioblastoma | 1.2% |
| 537 | Lymphoma, Extranodal NK-T-Cell | 1.2% |
| 538 | Anus Neoplasms | 1.2% |
| 539 | Sigmoid Neoplasms | 1.2% |
| 540 | Mastocytosis | 1.1% |
| 541 | Sturge-Weber Syndrome | 1.1% |
| 542 | Waldenstrom Macroglobulinemia | 1.1% |
| 543 | Multiple Myeloma | 1.1% |
| 544 | Cell Transformation, Viral | 1.1% |
| 545 | Gastrointestinal Stromal Tumors | 1.1% |
| 546 | Hemangioma, Cavernous | 1.1% |
| 547 | Leukemia, T-Cell | 1.1% |
| 548 | Leukemia, B-Cell | 1.1% |
| 549 | neurofibroma | 1.1% |
| 550 | Lymphoma, Follicular | 1.1% |
| 551 | T-Cell Lymphoma | 1.1% |
| 552 | Mantle cell lymphoma | 1.1% |
| 553 | Fibromatosis, Aggressive | 1% |
| 554 | Fibromatosis, Abdominal | 1% |
| 555 | Klatskin Tumor | 1% |
| 556 | Zollinger-Ellison syndrome | 1% |
| 557 | Mastocytoma | 1% |
| 558 | Mastocytosis, Systemic | 1% |
| 559 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 560 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 561 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 562 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 563 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 564 | Lymphoma, AIDS-Related | 0.8% |
| 565 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 566 | Primary Effusion Lymphoma | 0.8% |
| 567 | Dupuytren Contracture | 0.7% |
| 568 | Urticaria Pigmentosa | 0.7% |
| 569 | Mycosis Fungoides | 0.7% |
| 570 | Lymphomatoid Papulosis | 0.7% |
| 571 | Plasmablastic lymphoma | 0.7% |
| 572 | Burkitt Lymphoma | 0.6% |
| 573 | Sezary Syndrome | 0.5% |
| 574 | Radicular Cyst | 0.5% |
